Morgan Stanley’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,543
Closed -$16.4K 8464
2025
Q4
$16.4K Buy
7,543
+6,980
+1,240% +$28.4K ﹤0.01% 6755
2025
Q3
$3.1K Sell
563
-1,197
-68% -$9.15K ﹤0.01% 7205
2025
Q2
$13.2K Sell
1,760
-311
-15% -$2.26K ﹤0.01% 6778
2025
Q1
$13.6K Sell
2,071
-224
-10% -$2.65K ﹤0.01% 6707
2024
Q4
$30.2K Buy
2,295
+1,739
+313% +$17.9K ﹤0.01% 6448
2024
Q3
$3.16K Sell
556
-47
-8% -$312 ﹤0.01% 7033
2024
Q2
$3.54K Sell
603
-3,648
-86% -$32.6K ﹤0.01% 6945
2024
Q1
$38.5K Sell
4,251
-15,719
-79% -$187K ﹤0.01% 6310
2023
Q4
$220K Buy
19,970
+17,890
+860% +$199K ﹤0.01% 5905
2023
Q3
$36.9K Sell
2,080
-3,558
-63% -$130K ﹤0.01% 6289
2023
Q2
$310K Buy
5,638
+708
+14% +$45.1K ﹤0.01% 5454
2023
Q1
$336K Sell
4,930
-2,502
-34% -$195K ﹤0.01% 5469
2022
Q4
$450K Buy
7,432
+5,656
+318% +$526K ﹤0.01% 5300
2022
Q3
$179K Buy
1,776
+1,189
+203% +$139K ﹤0.01% 5779
2022
Q2
$52K Sell
587
-482
-45% -$58.9K ﹤0.01% 6593
2022
Q1
$162K Buy
1,069
+519
+94% +$96.6K ﹤0.01% 6036
2021
Q4
$175K Sell
550
-2,347
-81% -$828K ﹤0.01% 6137
2021
Q3
$1.3M Buy
2,897
+2,753
+1,912% +$872K ﹤0.01% 4879
2021
Q2
$43K Hold
144
﹤0.01% 6730
2021
Q1
$43K Buy
+144
New +$44.1K ﹤0.01% 6413

Other funds holding RBOT

Morgan Stanley's RBOT Position: Q1 2026 in Review

Morgan Stanley sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 7,543 shares — an estimated $16.4K sold.

Morgan Stanley first reported a position in RBOT in Q1 2021 and held it in 20 quarters. The position peaked at $1.3M in Q3 2021. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Morgan Stanley reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 7,543 Vicarious Surgical shares in Q1 2026, an estimated $16.4K.
  • Morgan Stanley first reported a position in Vicarious Surgical in Q1 2021 and held it in 20 quarters.
  • Morgan Stanley's Vicarious Surgical position peaked at $1.3M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.